for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Kyowa Kirin Says Presented Impact Of Baseline Dyskinesia On Safety And Efficacy Of Nourianz In Patients With Parkinson's Disease

May 26 (Reuters) - Kyowa Kirin Co Ltd:

* KYOWA KIRIN CO LTD - IMPACT OF BASELINE DYSKINESIA ON SAFETY AND EFFICACY OF NOURIANZ IN PATIENTS WITH PARKINSON’S DISEASE PRESENTED

* KYOWA KIRIN - PATIENTS HAD REDUCTIONS IN “OFF” TIME AND INCREASES IN “ON” TIME WITHOUT TROUBLESOME DYSKINESIA REGARDLESS OF DYSKINESIA AT BASELINE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up